Personal information

No personal information available

Activities

Employment (1)

Sanofi SA: Paris, Île-de-France, FR

2008-02-01 to present | Clinical lead (Oncology)
Employment
Source: Self-asserted source
patrick Cohen

Works (3)

Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Primary Results From AMEERA-5

Journal of Clinical Oncology
2024-08-01 | Journal article
Contributors: Javier Cortés; Sara A. Hurvitz; Joyce O'Shaughnessy; Suzette Delaloge; Hiroji Iwata; Hope S. Rugo; Patrick Neven; Dheepak Kanagavel; Patrick Cohen; Gautier Paux et al.
Source: check_circle
Crossref

Joint modeling of tumor dynamics and progression‐free survival in advanced breast cancer: Leveraging data from amcenestrant early phase I–II trials

CPT: Pharmacometrics & Systems Pharmacology
2024-06 | Journal article
Contributors: Marc Cerou; Hoai‐Thu Thai; Laure Deyme; Sophie Fliscounakis‐Huynh; Emmanuelle Comets; Patrick Cohen; Sylvaine Cartot‐Cotton; Christine Veyrat‐Follet
Source: check_circle
Crossref

Reply to Y. Yoshitomi et al

Journal of Clinical Oncology
2024-01-10 | Journal article
Contributors: Sara M. Tolaney; Elisabeth De Kermadec; Patrick Cohen; Gautier Paux; Lei Wang; Seock-Ah Im
Source: check_circle
Crossref